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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYMaintaining genomic integrity during DNA replication is essential for stem cells. DNA replication origins are licensed by the MCM2–7
complexes, withmost of them remaining dormant. Dormant origins (DOs) rescue replication fork stalling in S phase and ensure genome
integrity. However, it is not knownwhether DOs exist and play important roles in any stem cell type. Here, we show that embryonic stem
cells (ESCs) contain more DOs than tissue stem/progenitor cells such as neural stem/progenitor cells (NSPCs). Partial depletion of DOs
does not affect ESC self-renewal but impairs their differentiation, including toward the neural lineage. However, reduction of DOs in
NSPCs impairs their self-renewal due to accumulation of DNA damage and apoptosis. Furthermore, mice with reduced DOs show
abnormal neurogenesis and semi-embryonic lethality. Our results reveal that ESCs are equipped with more DOs to better protect against
replicative stress than tissue-specific stem/progenitor cells.INTRODUCTION
It is essential for stem cells, especially embryonic stem cells
(ESCs), tomaintain genome integrity. A key aspect of this is
to ensure the fidelity of DNA replication. In eukaryotic ge-
nomes, DNA replication initiates at thousands of origins.
Origins are licensed prior to S phase, a process that involves
the recruitment of licensing factors MCM2, 3, 4, 5, 6, and 7
as double heterohexamers onto DNA (Evrin et al., 2009;
Remus et al., 2009). During S phase, each MCM2–7 com-
plex can initiate replication by acting as a helicase to un-
wind double-stranded DNA ahead of DNA polymerases
(Bochman and Schwacha, 2009). MCM2–7 complexes are
loaded onto the genome in 5- to 20-fold excess to the num-
ber utilized to initiate DNA replication. The excess MCM2–
7 complexes usually remain dormant, but they initiate
back-up replication forks to rescue replication when pri-
mary forks are slowed or stalled; therefore, they are called
dormant origins (DOs) (Doksani et al., 2009; Ge and
Blow, 2010; Ge et al., 2007; Ibarra et al., 2008). Replication
forks frequently stall, for example, when encountering
tightly bound protein-DNA complexes, transcription ma-
chinery, repetitive sequences, or DNA lesions (Makovets
et al., 2004; Mirkin andMirkin, 2007). Prolonged fork stall-
ing increases the probability of fork collapse and double
strand breaks, which could lead to chromosomal re-ar-
rangements and genomic instability (Lambert et al.,Stem C2005). As a safeguard mechanism, DOs provide the first
line of defense against fork stalling (Blow and Ge, 2009).
Chromosomal fragile sites, which are prone to breakage
upon replication stress, are shown to have lower capacity
to activate DOs (Letessier et al., 2011). Mice with reduced
DOs show genomic instability, age-related dysfunction,
and develop tumors (Kunnev et al., 2010; Pruitt et al.,
2007; Shima et al., 2007). Importantly, congenital hypo-
morphic MCM4 defects have been found in humans, asso-
ciated with various abnormalities and elevated genomic
instability (Gineau et al., 2012; Hughes et al., 2012).
Despite the importance of DOs, it is unknown whether
they exist and function differently in stem cells. Here, we
analyze DOs in ESCs and neural stem/progenitor cells
(NSPCs) as an example of tissue stem/progenitor cells. We
show that ESCs load more DOs onto the genome than
NSPCs and that DOs play a significant role in defending
against replication stress in both stem cell types.RESULTS
ESCs License More DOs Than NSPCs
First, we investigated whether DOs exist in ESCs. DNA fiber
assay was used to measure the density of replication forks,
which involves labeling of the nascent strand DNA by
BrdUpulse and visualizationof labeledDNAafter spreadingell Reports j Vol. 5 j 185–194 j August 11, 2015 j ª2015 The Authors 185
onmicroscopic slides. DNA fibers containing at least a clus-
ter of four consecutive BrdU-incorporated forks were cho-
sen for analysis (e.g., Figure 1A). The average fork spacing
within each cluster (i.e., mean intra-cluster fork spacing)
was measured. The average fork spacing of the sample was
calculated from the mean intra-cluster fork spacing of
over 50 clusters (Figure 1B). ESCs have an average fork
spacing of25 kb, implying an average origin-to-origin dis-
tance of50 kbwithin replicon clusters, consistentwith re-
plicon sizes inothermammalian cells (Berezney et al., 2000;
Ge et al., 2007; Kawabata et al., 2011). After treatment with
hydroxyurea (HU) that inhibits ribonucleotide reductase,
replication forks in ESCs slowed down by 50% and the
average fork spacing reduced to 16 kb (Figures 1A and
1B). These results show that DOs are activated in ESCs in
response to replication stress.
Next, we compared the number ofDOs in ESCs and tissue
stem cells, using NSPCs as an example. Because 80%–95%
of the chromatin-bound MCM2–7 complexes are DOs,
we quantified the complexes on the chromatin by immu-
noblotting (Figure 1C). ESCs contain 2-fold more chro-
matin-boundMCM2–7 complexes than NSPCs. To exclude
non-cycling cells from the analysis, we immunostained
chromatin-boundMCM2and analyzed the cells by flow cy-
tometry. As licensing of replication origins starts at late
mitosis and reaches the maximum at G1 phase, we quanti-
fied the chromatin-bound MCM2 in G1-phase ESCs and
NSPCs. In line with the immunoblot results, ESCs contain
2-fold more chromatin-bound MCM2–7 complexes than
NSPCs (Figure 1D). Furthermore, we used super-resolution
3D structured illumination microscopy (SIM) to quantify
the chromatin-bound MCM2–7 complexes. SIM reaches
120 nm resolution in the x and y axis and 300 nm in the
Z axis (Figure 1E), and a double hexameric MCM2–7 com-
plex on DNA measures 25 3 16 nm (Evrin et al., 2009;
Remus et al., 2009). Hence, each focus observed by SIM
contains multiple MCM2–7 complexes. Quantification of
chromatin-bound MCM2, MCM3, and MCM7 foci in G1
phase cells shows approximately twice more MCM2–7
complexes in ESCs than in NSPCs (Figures 1F, upper panel,
and S5A). Because the average volume ofMCM foci in ESCs
is larger than in NSPCs, the difference of the chromatin-
bound MCM2–7 complexes between ESCs and NSPCs is
likely even greater (Figure 1F, lower panel). All the above
data together demonstrate that ESCs possess 2-fold
more chromatin-boundMCM2–7 complexes and therefore
more DOs than NSPCs.
Finally, DNA fiber assay shows similar overall fork
spacing in both ESCs and NSPCs (26 kb; Figure 1G, left
panel), suggesting a similar usage of primary origins. How-
ever, after HU treatment, average fork spacing reduces to
16 kb in ESCs and only to 19 kb in NSPCs (Figure 1G,
right panel), confirming fewer DOs in NSPCs than ESCs.186 Stem Cell Reports j Vol. 5 j 185–194 j August 11, 2015 j ª2015 The AutReducing DOs Impairs ESC Differentiation, but Not
Self-Renewal
We next examined the function of DOs in ESCs by knock-
ing down MCM5 using siRNAs. In order to reduce DOs
while keeping primary origins intact, we titrated out the
Mcm5 siRNAs to achieve 60% MCM5 knockdown in
ESCs while maintaining a normal rate of cellular prolifera-
tion and DNA replication (Figures 2A, 2B, and S1A, upper
panel). DNA fiber assay shows a similar average fork
spacing between the siRNA-treated cells and the control,
confirming that the usage of primary origins is unaffected.
However, upon adding HU, activation of DOs is greatly
reduced in the siRNA-treated cells (Figure S2A), and ESCs
show hypersensitivity to replication inhibitors HU and
aphidicolin, including a hyper-activation of DNA damage
response proteins, a further reduction of the overall rate
of DNA replication, and a significant increase of apoptosis
(Figures 2B, 2C, and S1A, lower panel). These results
demonstrate that DOs are required for ESCs to rescue repli-
cation fork stalling and to survive replication stress.
To avoid the transient effect of siRNAs, we derived ESCs
from the Mcm4Chaos3 mice that contain a point mutation
within the Mcm4 gene, resulting in the unstable MCM2–
7 complexes and thus reduced DOs on chromatin (Kawa-
bata et al., 2011). We assayed four Mcm4Chaos3/Chaos3
(Mcm4C/C) ESC lines and four wild-type controls (Mcm4+/+).
Immunoblotting shows a partial reduction of the chro-
matin-bound MCM2–7 complexes in the Mcm4C/C ESCs
(Figure S1C). Consistent with the Mcm5-siRNA-treated
ESCs, the overall rates of proliferation and DNA replica-
tion of the Mcm4C/C ESCs are normal compared with the
wild-type ESCs (Figures 2D, S1D, and S1E). The Mcm4C/C
ESCs also maintain pluripotency: there are 80%–95% of
Oct4, Sox2, and SSEA-1-positive cells in the Mcm4C/C
ESC culture, similar to the control (Figures 2E, S1F,
and S1G). Expectedly, the Mcm4C/C ESCs are hypersensi-
tive to replication fork inhibitors HU and aphidicolin
(Figures 2F, S1H, and S1I).
BecauseMcm4C/C ESCsmaintain normal self-renewal, we
examined their differentiation. As they differentiate into
NSPCs, they show increased cell death and decreased
expression of NSPC markers NESTIN and SOX1 (Figures
2G–2I, S2A, and S2B). In addition, they show defective dif-
ferentiation toward embryoid bodies, displaying abnormal
morphology and compromised expression of neuroecto-
derm, endoderm, and mesoderm markers (Figures 2J, 2K,
and S2C). To further assess their differentiation capability
in vivo, we injected them into immune-compromised
mice and allowed them to form teratomas. Although the
cellular composition of the Mcm4C/C and the wild-type
ESC-derived teratomas is similar (Figure S2D), the Mcm4C/C
ESCs generate 50% fewer teratomas and these teratomas
weigh 50% less than those derived from the wild-typehors
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Figure 1. ESCs Possess More DOs Than NSPCs
(A and B) DNA fiber assay on mouse ESCs (CCE
strain). For exclusion of artifacts arising from
fork-to-fork fusion, cells were pulsed with BrdU
for 10 min in the absence of HU and 20 min in the
presence of HU to achieve similar replication fork
length. (A) Examples of a DNA fiber containing a
replicon cluster of four BrdU-labeled forks are
shown. (B) Distribution of the mean intra-cluster
fork spacing from >50 replicon clusters is shown.
Overall fork spacing ± SEM is indicated in the
chart.
(C–G) Comparisons between CCE cells derived
from the 129/Sv mice and NSPCs from the E13.5
129/Sv embryo brains. (C) Immunoblotting of
chromatin-bound MCM proteins with H3 as a
loading control for quantification is shown. (D)
Quantification of chromatin-bound MCM2 in G1-
phase cells and cell-cycle distribution by FACS
are shown. (E) 2D projection confocal and SIM
images of chromatin-bound MCM2, MCM3, and
MCM7 in G1 phase cells are shown. (F) Quantifi-
cation of chromatin-bound MCM foci number and
average focus volume imaged by SIM are shown.
Error bars represent SEM of three independent
experiments. (G) DNA fiber analysis of NSPCs and
ESCs is shown. Cells were incubated with 100 mM
HU for 4 hr before BrdU pulse. Overall fork
spacing ± SEM from >50 replicon clusters is
indicated. p values are from two-tailed t test.
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controls (Figures 2L and S2E). Together, these data suggest
that, upon reduction of DOs, ESCs maintain normal self-
renewal but are impaired in differentiation. This is consis-
tent with our observation that ESCs load more DOs than
NSPCs. As a result, the self-renewal of ESCs is more robust
against DO reduction than differentiation.
Reducing DOs Impairs ESC Differentiation to NSPCs
We further investigated the differentiation of theMcm4C/C
ESCs into NSPCs. Mcm4C/C ESC-derived NSPCs show hy-
per-activation of phosphorylated CHK1, P53, and H2AX
and increased apoptosis (CASPASE 3 cleavage and 3-fold in-
crease in TUNEL staining; Figures 3A, 3B, and S3A–S3C).
Addition of caffeine, an ATM/ATR inhibitor, or the
CASPASE inhibitor Z-VAD-FMK during NSPC differentia-
tion largely rescued the differentiation efficiency, as shown
by the increased expression of NESTIN and SOX1 (Figures
3C and S3C). The partial nature of the rescue could be
due to the key role of ATR kinase during DNA replication
and cell-cycle progression (Jirmanova et al., 2005; Ruzan-
kina et al., 2007). Despite this, the above data clearly illus-
trate a functional relationship between reduced DOs and
impaired neural differentiation of the Mcm4C/C ESCs due
to elevated DNA damage response and cell death. The
defect in the neural differentiation of the Mcm4C/C ESCs
is likely due to compromised survival of differentiating
cells.
To confirm our in vitro findings on neural differentia-
tion, we isolated NSPCs from the Mcm4C/C mice during
embryogenesis. NSPCs from the forebrain of the E13.5
Mcm4C/C embryos generated 50% fewer neurospheres
than the wild-type NSPCs, even though both expressed
similar level of NESTIN and SOX2 (Figures 3D, S3D, and
S3E). In addition, NSPCs from the Mcm4C/C embryos lost
clonogenic ability after four to six passages, whereas the
wild-type NSPCs continue to form neurospheres (Fig-
ure 3E). DNA fiber assay revealed a significant lack of DOsFigure 2. Reducing DOs Impairs ESC Differentiation
(A) CCE cell proliferation at 48–96 hr after transfection with a serial
efficiency is achieved.
(B) Immunoblotting of total cell lysate at 72 hr afterMcm5 siRNA trans
no effect on cell growth or DNA replication; hence, it was used for fu
(C) TUNEL assay of ESCs after treatment with 500 mM HU or 0.075 mg/m
siRNA was transfected into the cells 72 hr prior to the HU and Aph tr
(D–K) Assays on Mcm4C/C ESCs (C1 and C2) and wild-type Mcm4+/+ ES
shown. (E) Overlay of OCT4 or SOX2 immunofluorescence images with D
are mostly MEF contamination in the ESC culture. (F) TUNEL assay of ES
images and immunofluorescence of NESTIN, respectively, of NSPCs at 9
analysis of Nestin and Sox1 expression during induced NSPC differentia
germ layer markers from days 1 to 13 during embryoid body (EB) differ
induced differentiation from ESCs are shown.
(L) Frequency and average weight of teratomas generated from the w
Error bars in (A), (D), (F), (I), and (J) all represent SEM of three inde
Stem Cin the Mcm4C/C NSPCs as compared with wild-type NSPCs
(Figure 3F). Furthermore, there is increased cell death in
the Mcm4C/C neurosphere culture and a blockage of these
NSPCs at the G2-M phase (Figures 3G and S3F). Elevated
DNA damage markers gH2AX, 53BP1, and phospho-P53
were also observed in the Mcm4C/C NSPCs (Figures 3H
and 3I). Together, these data show abnormal proliferation
and differentiation of the NSPCs in the Mcm4C/C embry-
onic mice brains.
Reduction of DOs Impairs Embryonic Neurogenesis
and Compromises Embryonic Viability
To investigate the in vivo properties ofMcm4C/CNSPCs, we
examined different stages of neurogenesis in the Mcm4C/C
embryos. At E13.5 and E15.5, Mcm4C/C embryos show a
reduction in the size of the ventral forebrain and the cortex
compared to the wild-type (Figures 4A–4C). The discrete at-
rophy of ganglionic eminences and the thinning of cortex
indicate that early neurogenesis is globally impaired in the
Mcm4C/C embryos. The ventricular layer of the PAX6+ radial
glia cells, i.e., neural stem cells, is however of similar size in
the Mcm4C/C and wild-type embryos (Figure 4D, upper
panel), suggesting that the formation and self-renewal of
neural stem cells are not significantly altered by the partial
loss of MCM4 function. In contrast, the number of inter-
mediate progenitor cells (TBR2+) in the cortical wall of
the E13.5 Mcm4C/C embryos is significantly reduced
compared to the wild-type (Figure 4D, middle panel), indi-
cating a defect in neural stem cell differentiation and/or
migration during early neurogenesis. Intermediate progen-
itor cells proliferate rapidly andmigrate to give rise to post-
mitotic neurons of the cerebral cortex. Consistently, the
number of early-born post-mitotic neurons (TBR1+) was
reduced in the cortical plate of the E15.5 Mcm4C/C brains
(Figure 4D, lower panel). Furthermore, the Mcm4C/C mu-
tants displayed anomalies in cell proliferation and survival
within the cortex (Figure 4E): a reduction of mitotic cellsdilution of Mcm5 siRNA. SC, scrambled siRNA. 90% transfection
fection. Fifteen picomolesMcm5 siRNA knocked down MCM5 and had
rther analysis.
l aphidicolin (Aph) for 48 hr. Fifteen picomoles Mcm5 or scrambled
eatment.
Cs (W1 and W2). (D) Cell proliferation rate analyzed over 72 hr is
IC images is shown. OCT4- or SOX2-negative cells, larger than ESCs,
Cs after treatment with HU or Aph for 48 hr is shown. (G and H) DIC
6 hr after induced differentiation from ESCs are shown. (I) qRT-PCR
tion from ESCs is shown. (J) qRT-PCR data of the expression of three
entiation from ESCs are shown. (K) DIC images of EBs at day 13 after
ild-type (W1–W4) and Mcm4C/C (C1–C4) ESCs.
pendent experiments. See also Figures S1 and S2.
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(phospho-HISTONEH3+) and an increase of apoptotic cells
(cleaved-CASPASE3+) were detected in the sub-ventricular
and intermediate zones, suggesting that cell death contrib-
utes initially to the attrition of intermediate progenitor cell
pool and then to the reduction of cortical neurons. Conse-
quently, a thinning of the cerebral cortex was observed in
the E19.5 Mcm4C/C brains (Figure S4A). However, at this
late stage of development, intermediate progenitor cell for-
mation has recovered and the Mcm4C/C-caused defects in
neurogenesis other than cortex were no longer detectable,
likely due to tissue homeostasis during development
(Figure S4B).
Beyond neurogenic defects, only 40% of Mcm4C/C mice
are viable (Figure S4C). Because the homozygotes are pre-
sent at the correct ratio at E13.5, E15.5, and E19.9, the
Mcm4C/C fetus likely dies shortly after birth. The semi-
lethality of the Mcm4C/C mice is consistent with the
in vitro differentiation defect of the Mcm4C/C ESCs.DISCUSSION
We have demonstrated that ESCs recruit 2-fold more
DOs onto the genome than NSPCs. Upon reduction of
DOs, the self-renewal of ESCs is unaffected, whereas their
differentiation including toward NSPCs is impaired. This
is due to a further reduction of DOs in NSPCs, presumably
below the threshold required to rescue the endogenous
fork stalling during DNA replication (Figure 4F). As a
result, DNA damage is accumulated and cell death incurs,
eventually leading to impaired neurogenesis in the
Mcm4C/C mice. ESCs have been shown to employ unique
mechanisms to maintain a more-stable genome than so-
matic cells, including efficient DNA repair, elimination
of damaged cells, antioxidant defense, and suppression
of mutagenesis (Giachino et al., 2013). Our study adds a
new dimension to these unique properties by showing
that ESCs use more DOs to effectively protect theirFigure 3. Reducing DOs Impairs the Differentiation of NSPCs
(A–C) Analysis of the NSPC differentiation from the Mcm4+/+ (W1 and W
lysate is shown. (B) TUNEL assay on NSPCs at 96 hr after induced diff
NSPCs is shown. Treatment with caffeine (4 mM) or Z-VAD-FMK (40 mM
for analysis.
(D–I) Analysis of neurospheres clonally derived from NSPCs isolated fro
6 days to give a new round of clonogenic assay. Number and growth rat
the total number of cells at each passage. Error bars represent SEM from
embryos of each genotype. (E) Representative images of neurosphere
were treated with 100 mM HU for 4 hr before analysis. Overall average
from two-tailed t test. (G) Cell-cycle analysis of neurospheres at fifth p
M blockage of the cells in the Mcm4C/C neurospheres. Two-tailed t te
quantifying the percentage of gH2AX or 53BP1 positive cells in neuros
is shown.
Error bars in (B), (C), (G), and (H) all represent SEM of three indepen
Stem Cgenomes from replication stress and ensure their genome
integrity.
It remains elusive how ESCs recruit a larger number of
DOs than tissue stem/progenitor cells during DNA
licensing. It is possible that ESCs express a higher level of
proteins thatmediate DNA licensing. Alternatively, it could
be due to their open and hyper-dynamic chromatin struc-
ture (Mattout and Meshorer, 2010), which facilitates
MCM2–7 loading (Miotto and Struhl, 2010; Sugimoto
et al., 2011; Swarnalatha et al., 2012; Wong et al., 2010).
Because NSPCs possess fewer DOs than ESCs, when DOs
are reduced, neurogenesis is more severely affected. Our
findings may be related to the severe neurogenic defect in
theMeier-Gorlin syndrome patients, who are characterized
by mutations in replication licensing components and
reduction in origin licensing (Bicknell et al., 2011; Kerzen-
dorfer et al., 2013). In addition to NSPCs, other tissue stem/
progenitor cells may possess fewer DOs than ESCs, because
Mcm4C/C ESCs display broad in vitro differentiation defects.
The neurogenic defect together with other organ abnor-
malities could collectively contribute to the semi-embry-
onic lethality of theMcm4C/C mice. Future studies in other
tissue stem cells in the Mcm4C/C mice will allow further
understanding of the growth retardation and other defi-
ciencies associated with the hypomorphic MCM4 condi-
tions in human patients.EXPERIMENTAL PROCEDURES
The Mcm4chaos3/chaos3 and wild-type mouse ESC lines were
derived from the blastocysts by crossing the Mcm4chaos3/+ mice.
They were maintained on MEF feeder in standard ESC culture
medium. CCE mouse ESCs were grown without feeder. siRNA
was transfected into ESCs by Lipofectamine 2000 according to
manufacturer’s instructions. NSPCs were isolated from the fore-
brain of E13.5 mice and cultured as described in Supplemental
Information. Neurosphere culture on day 6 was dissociated
into single cells and plate at 1,000 cells/ml to initiate clonal2) and Mcm4C/C (C1 and C2) ESCs. (A) Immunoblot of the NSPC total
erentiation is shown. (C) qRT-PCR of Nestin and Sox1 expression in
) started at 48 hr after induction, and NSPCs were harvested at 96 hr
m the E13.5 mouse forebrain. (D) Neurospheres were passaged every
e of neurospheres were measured by counting the neurospheres and
four independent experiments and each experiment containing five
s at fifth passage are shown. (F) DNA fiber analysis is shown. Cells
fork spacing ± SEM from >50 replicon clusters is shown. p values are
assage by FACS after pyronin Y and DAPI staining is shown. Note G2-
st: non-significant (ns); p < 0.005 (**). (H) Immunofluorescence
pheres is shown. (I) Immunoblot of total cell lysate of neurospheres
dent experiments. See also Figure S3.
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neurosphere assays. DNA fiber, chromatin-bound MCMs analysis
by immunoblotting, and FACS were carried out as previously
described (Ge et al., 2007). Embryonic brains from the E13.5,
15.5, and 19.5 mice were dissected, cryosectioned, and immuno-
stained with various antibodies, including TBR2, P-H3, and
cleaved-CASPASE 3 where positive cells were counted and
PAX6 and TBR1 where the thickness of cell layer was measured.
The rate of DNA synthesis was measured by pulse labeling cells
with Click-iT EdU Alexa Fluor 647 Flow Cytometry kit (Invitro-
gen) according to manufacturer’s instruction. Cell growth rate
was assayed with the alamarBlue CellViability Reagent (Invitro-
gen), and apoptosis was assayed by ApopTag Fluorescein In
Situ Apoptosis Detection Kit (Millipore) according to the manu-
facturer’s instructions. NSPC differentiation was performed as
previously described using the N2B27 medium (Ying et al.,
2003). Embryoid body differentiation was achieved by hanging
drop method (Jackson et al., 2010). The differentiation efficiency
into the ectoderm, mesoderm, and endoderm was assessed by
qRT-PCR using lineage-specific primers (Nestin, Sox1, Sox17,
Goosecoid, Mash1, Fgf5, Mixl1, and Foxa2). For imaging of the
chromatin-bound MCM foci, cells were synchronized by thymi-
dine followed by nocodazole. Delta Vision OMX imaging system
(Applied Precision) was used to collect 3D images, followed by
analysis with Volocity (PerkinElmer), where a threshold-based
segmentation was applied.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures and four figures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.stemcr.2015.06.002.AUTHOR CONTRIBUTIONS
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(A and B) Coronal sections of the Mcm4+/+ and Mcm4C/C embryonic fore
ventral forebrain (VF) and thickness of cortex (Cx). (B) Quantificatio
(C) DAPI staining and measurement of the E15.5 cortex: ventricular/s
plate (CP).
(D) Cortex coronal sections with immunolabeling of VZ/SVZ stem/pr
early born, deep-layer cortical neurons (TBR1+).
(E) Immunolabeling of phospho-H3 and cleaved-CASPASE 3 (c-CASP3
represent SEM of three independent experiments comprising in total fi
and seven Mcm4C/C embryos at E15.5. Two-tailed t test: ns; p < 0.05
(F) Model. Black and orange colors indicate the conditions of the wi
respectively. In the wild-type ESCs, DOs initiate back-up replication
possess a greater number of DOs than NSPCs. Upon reduction of DO, t
threshold required to rescue the endogenous fork stalling during DNA
incurs, eventually impairing NSPC proliferation and differentiation. T
could contribute to the semi-embryonic lethality of the Mcm4C/C mic
See also Figure S4.
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